Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Biologics Market
The global biologics market was valued at approximately US$ XX billion in 2023 and is projected to reach around US$ XX billion by 2033, with a compound annual growth rate (CAGR) of XX% from 2024 to 2033. The significant expansion of the biologics market is attributed to the profound impact of biologics on patient outcomes in treating cancer, autoimmune disorders, and various other conditions. Unlike traditional medications, biologics are derived from complex biological sources, including blood, proteins, viruses, and living organisms, ranging from whole cells and tissues to sugars, proteins, and DNA. These diverse origins, which include human, animal, and bacterial sources, contribute to the potent efficacy of biologics in preventing, treating, and curing a wide range of medical conditions. As a result, the growing demand and advancements in biologics are driving substantial market growth, establishing biologics as a crucial sector within the pharmaceutical industry.
Market Overview Biologic medicines, made from living cells or organisms, are unique and powerful, leading to the rapid expansion of the biologics market. These medicines include monoclonal antibodies, recombinant proteins, gene therapies, transplant tissues, and stem cell therapies, all vital for treating severe and potentially fatal diseases. Biologics differ from traditional pharmaceuticals in their manufacturing processes, regulatory requirements, and material sources, and they are often more expensive, potentially limiting patient access. Their ability to transform the prognosis, treatment, and prevention of numerous severe conditions highlights their market significance. Biologics are produced using biotechnology and other advanced technologies from various natural sources, including humans, animals, and microorganisms. This innovation and differentiation are key drivers of the market's rapid growth.
Key developments in the market include partnerships and collaborations:
May 2024: AGC Biologics and BioConnection partnered to provide new end-to-end biopharmaceutical drug substance and drug product development and manufacturing services. June 2024: Lotte Biologics and Merck KGaA entered into a partnership for biopharma production. October 2023: Samsung Biologics and Kurma Partners announced a strategic partnership for developing and manufacturing biologics for Kurma's portfolio companies.
Key Insights Regional Leadership: North America, particularly the United States, holds the largest market share, with biologics accounting for a significant portion of pharmaceutical spending. Asia Pacific Growth: The Asia Pacific region is expected to see rapid market growth during the forecast period. Dominant Source: The microbial segment leads the market, highlighting the importance of microorganisms in biologic production. Manufacturing Trends: The in-house manufacturing segment dominates the market share. Product Focus: The monoclonal antibodies segment holds a substantial market share, reflecting its critical role in targeted therapies.
Regional Stance North America, led by the United States, dominates the biologics market. In 2023, biologics accounted for 30% of all newly approved drugs, reflecting the region's strong investment and innovation in this field. The Asia-Pacific region is expected to grow at the fastest rate, driven by the increasing adoption of biologic therapies, including biosimilars, in countries like India and China.
Report Highlights By Source The microbial segment dominates the biologics market, driven by the production of diverse secondary metabolites with various therapeutic applications. This segment's growth is also fueled by the use of cultured mammalian cells, which are crucial for biopharmaceutical production due to their capability to perform essential posttranslational modifications.
By Product The monoclonal antibodies (mAbs) segment is the largest in the biologics market, known for their precise targeting of diseases. The vaccines segment is projected to grow rapidly, driven by the need to address emerging pandemics and chronic diseases.
By Disease The oncology segment leads the biologics market, with biologics being used extensively for cancer treatment. The cardiovascular diseases (CVD) segment is expected to grow rapidly, supported by the recognition of biologics' role in modulating inflammation in conditions like atherosclerosis and autoimmune rheumatic diseases.
Market Dynamics Drivers Biologics are revolutionizing the treatment of inflammatory autoimmune diseases and osteoporosis. These therapies have shown significant efficacy in clinical settings, improving patient outcomes and quality of life.
Restraints The high cost of biologics, driven by complex development processes and significant financial investment, poses challenges for patient access and market growth.
Opportunities Advancements in formulation technologies, such as microparticles, nanoparticles, and 3D printing, are enhancing the efficacy and patient compliance of biologics, presenting new opportunities for market expansion and innovation.
Recent Developments
May 2022: Viatris and Biocon Biologics launched Abevmy (Bevacizumab), their third oncology biosimilar, in Canada.
March 2024: Lonza acquired a large-scale biologics site in Vacaville, US, from Roche.
April 2022: Samsung Biologics completed the acquisition of Samsung Bioepis.
Key Players in the Biologics Market Eli Lilly & Company Samsung Biologics F. Hoffman La Roche Celltrion Addgene Amgen Abbvie Inc. Sanofi Pfizer Inc. Merck & Co. Inc. Novo Nordisk A/S
By Indication Oncology Immunological Disorders Cardiovascular Disorders Hematological Disorders Others
By Manufacturing Outsourced In-house By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
Table of content 1. Introduction 1.1. Report Description 1.2. Research Methodology 1.2.1. Data Mining 1.2.2. Market Modeling and Forecasting 1.2.3. Data Validation 1.2.4. Industry Analysis
4. Global Biologics Market Market by Source Type 4.1. Introduction 4.2. Global Biologics Market Market Size and Growth Rate by Source Type (2021-2030) 4.3 Microbial 4.3.1 Microbial Market Size and Growth Rate (2019- 2030) 4.4. Mammalian 4.4.1. Mammalian Market Size and Growth Rate (2019- 2030) 4.5. Others 4.5.1. Others Market Size and Growth Rate (2021-2030)
5. Global Biologics Market Market by Product 5.1. Introduction 5.2. Global Biologics Market Market Size and Growth Rate by Product (2021-2030) 5.3. Monoclonal Antibodies 5.3.1. Monoclonal Antibodies Market Size and Growth Rate (2021-2030) 5.4. Human mABs 5.4.1. Human mABs Market Size and Growth Rate (2021-2030) 5.5. Humanized mABs 5.5.1. Humanized mABs Market Size and Growth Rate (2021-2030) 5.6. Chimeric mABs 5.6.1. Chimeric mABs Market Size and Growth Rate (2019- 2030) 5.7. Murine mABs 5.7.1. Murine mABs Market Size and Growth Rate (2021-2030) 5.8. Vaccines 5.8.1. Vaccines Market Size and Growth Rate (2021-2030) 5.9. RecombinantProteins 5.9.1. RecombinantProteins Market Size and Growth Rate (2021-2030) 5.7. Antisense, RNAi & molecular therapy 5.7.1. Antisense, RNAi & molecular therapy Market Size and Growth Rate (2021-2030) 5.8. Cell Based Therapies 5.8.1. Cell Based Therapies Market Size and Growth Rate (2021-2030) 5.9. Stem Cell Therapy 5.9.1. Stem Cell Therapy Market Size and Growth Rate (2021-2030) 5.7. CAR-T Cell Therapy 5.7.1. CAR-T Cell Therapy Market Size and Growth Rate (2021-2030) 5.8. Tissue Engineering 5.8.1. Tissue Engineering Market Size and Growth Rate (2021-2030) 5.9. Others 5.9.1. Others Market Size and Growth Rate (2021-2030)
6. Global Biologics Market Market by Indication 6.1. Introduction 6.2. Global Biologics Market Market Size and Growth Rate by Indication (2021-2030) 6.3. Oncology 6.3.1. Oncology Market Size and Growth Rate (2021-2030) 6.4. Immunological Disorders 6.4.1. Immunological Disorders Market Size and Growth Rate (2021-2030) 6.5. Cardiovascular Disorders 6.5.1. Cardiovascular Disorders Market Size and Growth Rate (2021-2030) 6.6 Hematological Disorders 6.6.1. Hematological Disorders Market Size and Growth Rate (2021-2030) 6.7. Others 6.7.1. Others Market Size and Growth Rate (2021-2030)
7. Global Biologics Market Market by Manufacturing 7.1. Introduction 7.2. Global Biologics Market Market Size and Growth Rate by Manufacturing (2021-2030) 7.3. Outsourced 7.3.1. Outsourced Market Size and Growth Rate (2021-2030) 7.4. In-house 7.4.1. In-house Market Size and Growth Rate (2021-2030) 7.5. Specialty Clinics 7.5.1. Specialty Clinics Market Size and Growth Rate (2021-2030)
8. Global Biologics Market Market by Distribution Channel 8.1. Introduction 8.2. Global Biologics Market Market Size and Growth Rate by Distribution Channel (2021-2030) 8.3. Hospital Pharmacies 8.3.1. Hospital Pharmacies Market Size and Growth Rate (2021-2030) 8.4. Retail Pharmacies 8.4.1. Retail Pharmacies Market Size and Growth Rate (2021-2030) 8.5. Online Pharmacies 8.5.1 Online Pharmacies Market Size and Growth Rate (2021-2030)
9. Company Profiles 9.1. Eli Lilly & Company 9.1.1. Business Overview 9.1.2. Service Portfolio 9.1.3. Strategic Developments 9.1.4. Financial Overview
9.2. Samsung Biologics 9.2.1. Business Overview 9.2.2. Service Portfolio 9.2.3. Strategic Developments 9.2.4. Financial Overview
9.3. F. Hoffman La Roche 9.3.1. Business Overview 9.3.2. Service Portfolio 9.3.3. Strategic Developments 9.3.4. Financial Overview
9.4. Celltrion Addgene 9.4.1. Business Overview 9.4.2. Service Portfolio 9.4.3. Strategic Developments 9.4.4. Financial Overview
9.5. Amgen 9.5.1. Business Overview 9.5.2. Service Portfolio 9.5.3. Strategic Developments 9.5.4. Financial Overview
9.6. Abbvie Inc. 9.6.1. Business Overview 9.6.2. Service Portfolio 9.6.3. Strategic Developments 9.6.4. Financial Overview
9.7. Sanofi 9.7.1. Business Overview 9.7.2. Service Portfolio 9.7.3. Strategic Developments 9.7.4. Financial Overview
9.8. Pfizer Inc. 9.8.1. Business Overview 9.8.2. Service Portfolio 9.8.3. Strategic Developments 9.8.4. Financial Overview
9.9. Pfizer Inc. 9.9.1. Business Overview 9.9.2. Service Portfolio 9.9.3. Strategic Developments 9.9.4. Financial Overview
9.9. Merck & Co. Inc. 9.9.1. Business Overview 9.9.2. Service Portfolio 9.9.3. Strategic Developments 9.9.4. Financial Overview
9.11. Novo Nordisk A/S 9.11.1. Business Overview 9.11.2. Service Portfolio 9.11.3. Strategic Developments 9.11.4. Financial Overview
10. List of Tables and Figures Table Global Biologics Market Market Size and Market Share by Source Type (2021-2023) Table Global Biologics Market Market Size and Market Share by Source Type (2023-2030) Figure Microbial Market Size and Growth Rate (2021-2030) Figure Mammalian Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Global Biologics Market Market Size and Market Share by Product (2021-2023) Table Global Biologics Market Market Size and Market Share by Product (2023-2030) Figure Monoclonal Antibodies Market Size and Growth Rate (2021-2030) Figure Human mABs Market Size and Growth Rate (2021-2030) Figure Humanized mABs Market Size and Growth Rate (2021-2030) Figure Chimeric mABs Market Size and Growth Rate (2021-2030) Figure Murine mABs Market Size and Growth Rate (2021-2030) Figure Vaccines Market Size and Growth Rate (2021-2030) Figure Recombinant Proteins Market Size and Growth Rate (2021-2030) Figure Antisense, RNAi & molecular therapy Market Size and Growth Rate (2021-2030) Figure Cell Based Therapies Market Size and Growth Rate (2021-2030) Figure Stem Cell Therapy Market Size and Growth Rate (2021-2030) Figure CAR-T Cell Therapy Market Size and Growth Rate (2021-2030) Figure Tissue Engineering Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Global Biologics Market Market Size and Market Share by Indication (2021-2023) Table Global Biologics Market Market Size and Market Share by Indication (2023-2030) Figure Oncology Market Size and Growth Rate (2021-2030) Figure Immunological Disorders Market Size and Growth Rate (2021-2030) Figure Cardiovascular Disorders Market Size and Growth Rate (2021-2030) Figure Hematological Disorders Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030) Table Global Biologics Market Market Size and Market Share by Manufacturing (2021-2023) Table Global Biologics Market Market Size and Market Share by Manufacturing (2023-2030) Figure Outsourced Market Size and Growth Rate (2021-2030) Figure In-house Market Size and Growth Rate (2021-2030) Table Global Biologics Market Market Size and Market Share by Distribution Channel (2021-2023) Table Global Biologics Market Market Size and Market Share by Distribution Channel (2023-2030) Figure Hospital Pharmacies Market Size and Growth Rate (2021-2030) Figure Retail Pharmacies Market Size and Growth Rate (2021-2030) Figure Online Pharmacies Market Size and Growth Rate (2021-2030)
Table Global Biologics Market Market Size and Market Share by Product Type (2021-2023) Table Global Biologics Market Market Size and Market Share by Product Type (2023-2030) Figure Endoscopes Market Size and Growth Rate (2021-2030) Figure Surgical Instruments Market Size and Growth Rate (2021-2030) Figure Closure Devices Market Size and Growth Rate (2021-2030) Figure Accessories Market Size and Growth Rate (2021-2030) Table Global Biologics Market Market Size and Market Share by Technology (2021-2023) Table Global Biologics Market Market Size and Market Share by Technology (2023-2030) Figure Conventional Global Biologics Market Market Size and Growth Rate (2021-2030) Figure Robotic-Assisted Global Biologics Market Market Size and Growth Rate (2021-2030) Figure Other Advanced Technologies Market Size and Growth Rate (2021-2030) Table Global Biologics Market Market by Regions (2021-2023) Table Global Biologics Market Market by Regions (2023-2030) Figure North America Global Biologics Market Market Size and Growth Rate (2021-2030) Table North America Global Biologics Market Market by Type (2021-2023) Table North America Global Biologics Market Market by Type (2023-2030) Table North America Global Biologics Market by Application (2021-2023) Table North America Global Biologics Market by Application (2023-2030) Table North America Global Biologics Market by Country (2021-2023) Table North America Global Biologics Market by Country (2023-2030) Figure United States Global Biologics Market Market Size and Growth Rate (2021-2030) Table United States Global Biologics Market Market by Type (2021-2023) Table United States Global Biologics Market Market by Type (2023-2030) Table United States Global Biologics Market by Application (2021-2023) Table United States Global Biologics Market by Application (2023-2030) Figure Canada Global Biologics Market Market Size and Growth Rate (2021-2030) Table Canada Global Biologics Market Market by Type (2021-2023) Table Canada Global Biologics Market Market by Type (2023-2030) Table Canada Global Biologics Market by Application (2021-2023) Table Canada Global Biologics Market by Application (2023-2030) Figure Europe Global Biologics Market Market Size and Growth Rate (2021-2030) Table Europe Global Biologics Market Market by Type (2021-2023) Table Europe Global Biologics Market Market by Type (2023-2030) Table Europe Global Biologics Market by Application (2021-2023) Table Europe Global Biologics Market by Application (2023-2030) Table Europe Global Biologics Market by Country (2021-2023) Table Europe Global Biologics Market by Country (2023-2030) Figure Germany Global Biologics Market Market Size and Growth Rate (2021-2030) Table Germany Global Biologics Market Market by Type (2021-2023) Table Germany Global Biologics Market Market by Type (2023-2030) Table Germany Global Biologics Market by Application (2021-2023) Table Germany Global Biologics Market by Application (2023-2030) Figure France Global Biologics Market Market Size and Growth Rate (2021-2030) Table France Global Biologics Market Market by Type (2021-2023) Table France Global Biologics Market Market by Type (2023-2030) Table France Global Biologics Market by Application (2021-2023) Table France Global Biologics Market by Application (2023-2030) Figure UK Global Biologics Market Market Size and Growth Rate (2021-2030) Table UK Global Biologics Market Market by Type (2021-2023) Table UK Global Biologics Market Market by Type (2023-2030) Table UK Global Biologics Market by Application (2021-2023) Table UK Global Biologics Market by Application (2023-2030) Figure Russia Global Biologics Market Market Size and Growth Rate (2021-2030) Table Russia Global Biologics Market Market by Type (2021-2023) Table Russia Global Biologics Market Market by Type (2023-2030) Table Russia Global Biologics Market by Application (2021-2023) Table Russia Global Biologics Market by Application (2023-2030) Figure Italy Global Biologics Market Market Size and Growth Rate (2021-2030) Table Italy Global Biologics Market Market by Type (2021-2023) Table Italy Global Biologics Market Market by Type (2023-2030) Table Italy Global Biologics Market by Application (2021-2023) Table Italy Global Biologics Market by Application (2023-2030) Figure Rest of Europe Global Biologics Market Market Size and Growth Rate (2021-2030) Table Rest of Europe Global Biologics Market Market by Type (2021-2023) Table Rest of Europe Global Biologics Market Market by Type (2023-2030) Table Rest of Europe Global Biologics Market by Application (2021-2023) Table Rest of Europe Global Biologics Market by Application (2023-2030) Figure Asia-Pacific Global Biologics Market Market Size and Growth Rate (2021-2030) Table Asia-Pacific Global Biologics Market Market by Type (2021-2023) Table Asia-Pacific Global Biologics Market Market by Type (2023-2030) Table Asia-Pacific Global Biologics Market by Application (2021-2023) Table Asia-Pacific Global Biologics Market by Application (2023-2030) Table Asia-Pacific Global Biologics Market by Country (2021-2023) Table Asia-Pacific Global Biologics Market by Country (2023-2030) Figure China Global Biologics Market Market Size and Growth Rate (2021-2030) Table China Global Biologics Market Market by Type (2021-2023) Table China Global Biologics Market Market by Type (2023-2030) Table China Global Biologics Market by Application (2021-2023) Table China Global Biologics Market by Application (2023-2030) Figure Japan Global Biologics Market Market Size and Growth Rate (2021-2030) Table Japan Global Biologics Market Market by Type (2021-2023) Table Japan Global Biologics Market Market by Type (2023-2030) Table Japan Global Biologics Market by Application (2021-2023) Table Japan Global Biologics Market by Application (2023-2030) Figure India Global Biologics Market Market Size and Growth Rate (2021-2030) Table India Global Biologics Market Market by Type (2021-2023) Table India Global Biologics Market Market by Type (2023-2030) Table India Global Biologics Market by Application (2021-2023) Table India Global Biologics Market by Application (2023-2030) Figure Southeast Asia Global Biologics Market Market Size and Growth Rate (2021-2030) Table Southeast Asia Global Biologics Market Market by Type (2021-2023) Table Southeast Asia Global Biologics Market Market by Type (2023-2030) Table Southeast Asia Global Biologics Market by Application (2021-2023) Table Southeast Asia Global Biologics Market by Application (2023-2030) Figure Rest of Asia-Pacific Global Biologics Market Market Size and Growth Rate (2021-2030) Table Rest of Asia-Pacific Global Biologics Market Market by Type (2021-2023) Table Rest of Asia-Pacific Global Biologics Market Market by Type (2023-2030) Table Rest of Asia-Pacific Global Biologics Market by Application (2021-2023) Table Rest of Asia-Pacific Global Biologics Market by Application (2023-2030) Figure South America Global Biologics Market Market Size and Growth Rate (2021-2030) Table South America Global Biologics Market Market by Type (2021-2023) Table South America Global Biologics Market Market by Type (2023-2030) Table South America Global Biologics Market by Application (2021-2023) Table South America Global Biologics Market by Application (2023-2030) Table South America Global Biologics Market by Country (2021-2023) Table South America Global Biologics Market by Country (2023-2030) Figure Brazil Global Biologics Market Market Size and Growth Rate (2021-2030) Table Brazil Global Biologics Market Market by Type (2021-2023) Table Brazil Global Biologics Market Market by Type (2023-2030) Table Brazil Global Biologics Market by Application (2021-2023) Table Brazil Global Biologics Market by Application (2023-2030) Figure Mexico Global Biologics Market Market Size and Growth Rate (2021-2030) Table Mexico Global Biologics Market Market by Type (2021-2023) Table Mexico Global Biologics Market Market by Type (2023-2030) Table Mexico Global Biologics Market by Application (2021-2023) Table Mexico Global Biologics Market by Application (2023-2030) Figure Columbia Global Biologics Market Market Size and Growth Rate (2021-2030) Table Columbia Global Biologics Market Market by Type (2021-2023) Table Columbia Global Biologics Market Market by Type (2023-2030) Table Columbia Global Biologics Market by Application (2021-2023) Table Columbia Global Biologics Market by Application (2023-2030) Figure Rest of South America Global Biologics Market Market Size and Growth Rate (2021-2030) Table Rest of South America Global Biologics Market Market by Type (2021-2023) Table Rest of South America Global Biologics Market Market by Type (2023-2030) Table Rest of South America Global Biologics Market by Application (2021-2023) Table Rest of South America Global Biologics Market by Application (2023-2030) Figure Middle East and Africa Global Biologics Market Market Size and Growth Rate (2021-2030) Table Middle East and Africa Global Biologics Market Market by Type (2021-2023) Table Middle East and Africa Global Biologics Market Market by Type (2023-2030) Table Middle East and Africa Global Biologics Market by Application (2021-2023) Table Middle East and Africa Global Biologics Market by Country (2021-2023) Table Middle East and Africa Global Biologics Market by Country (2023-2030) Figure Saudi Arabia Global Biologics Market Market Size and Growth Rate (2021-2030) Table Saudi Arabia Global Biologics Market Market by Type (2021-2023) Table Saudi Arabia Global Biologics Market Market by Type (2023-2030) Table Saudi Arabia Global Biologics Market by Application (2021-2023) Table Saudi Arabia Global Biologics Market by Application (2023-2030) Figure United Arab Emirates Global Biologics Market Market Size and Growth Rate (2021-2030) Table United Arab Emirates Global Biologics Market Market by Type (2021-2023) Table United Arab Emirates Global Biologics Market Market by Type (2023-2030) Table United Arab Emirates Global Biologics Market by Application (2021-2023) Table United Arab Emirates Global Biologics Market by Application (2023-2030) Figure South Africa Global Biologics Market Market Size and Growth Rate (2021-2030) Table South Africa Global Biologics Market Market by Type (2021-2023) Table South Africa Global Biologics Market Market by Type (2023-2030) Table South Africa Global Biologics Market by Application (2021-2023) Table South Africa Global Biologics Market by Application (2023-2030) Figure Rest of Middle East and Africa Global Biologics Market Market Size and Growth Rate (2021-2030) Table Rest of Middle East and Africa Global Biologics Market Market by Type (2021-2023) Table Rest of Middle East and Africa Global Biologics Market Market by Type (2023-2030) Table Rest of Middle East and Africa Global Biologics Market by Application (2021-2023) Table Rest of Middle East and Africa Global Biologics Market by Application (2023-2030)
Table Olympus Corporation Global Biologics Market Financial Overview Table Medtronic Global Biologics Market Financial Overview Table Fujifilm Holdings Corporation Global Biologics Market Financial Overview Table Boston Scientific Corporation Global Biologics Market Financial Overview Table Johnson & Johnson (Ethicon) Global Biologics Market Financial Overview Table Karl Storz Global Biologics Market Financial Overview Table PENTAX Medical (Hoya Corporation) Global Biologics Market Financial Overview Table Cook Medical Global Biologics Market Financial Overview Table CONMED Corporation Global Biologics Market Financial Overview Table Stryker Corporation Global Biologics Market Financial Overview Table Apollo Endosurgery, Inc. (US) Global Biologics Market Financial Overview Table Endo Tools Therapeutics S.A. (Belgium) Global Biologics Market Financial Overview
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Biologics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Biologics Market for the past year and forecasts for the next six years. Global Biologics Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Biologics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biologics Market from different application industries in different regions.
By Indication Oncology Immunological Disorders Cardiovascular Disorders Hematological Disorders Others
By Manufacturing Outsourced In-house By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
